Evidence map›Paper›PMID 25389919›Full record

ArticleThe Pediatric infectious disease journal2015

Etiology of bacteremia in young infants in six countries.

Davidson H Hamer, Gary L Darmstadt, John B Carlin, Anita K M Zaidi, Kojo Yeboah-Antwi, Samir K Saha, Pallab Ray, Anil Narang, Eduardo Mazzi, Praveen Kumar and 11 more

Open access · hybridAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 7 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 7 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Feasibility of manual white blood cell counts as a predictor of neonatal sepsis in a low-resource setting.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2020
    Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 8 countries.

Davidson H HamerFrom the *Center for Global Health and Development, Boston University; Department of Global Health, Boston University School of Public Health; †Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts; ‡Global Development Division, Bill and Melinda Gates Foundation, Seattle, Washington; §Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Melbourne, Australia; ¶Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan; ‖Child Health Research Foundation, Dhaka, Bangladesh; **Post Graduate Institute of Medical Education and Research, Chandigarh, India; ††Department of Pediatrics, Hospital del Niño "Dr. Ovidio Aliaga Uría," La Paz, Bolivia; ‡‡Department of Microbiology, All India Institute for Medical Sciences, Delhi, India; §§Department of Paediatrics & Child Health, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa; ¶¶Department of Pediatrics, Division of Neonatology, All India Institute for Medical Sciences, Delhi, India; ‖‖Department of Neonatology, Dhaka Shishu Hospital, Dhaka, Bangladesh; ***Department of Pediatrics, Hospital Materno Infantil, La Paz, Bolivia; †††Center of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan; ‡‡‡Sick Kids Center for Global Child Health, Toronto, Canada; §§§School of Medical Sciences, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana; ¶¶¶World Health Organization Southeast Asian Regional Office, Delhi, India; and ‖‖‖Members of the YICSS Group are listed in Appendix 2.
Gary L Darmstadt
John B Carlin
Anita K M Zaidi
Kojo Yeboah-Antwi
Samir K Saha
Pallab Ray
Anil Narang
Eduardo Mazzi
Praveen Kumar
Arti Kapil
Prakash M Jeena
Ashok Deorari
A K Azad Chowdury
Andrés Bartos
Zulfiqar A Bhutta
Yaw Adu-Sarkodie
Miriam Adhikari
Emmanuel Addo-Yobo
Martin W Weber
Young Infants Clinical Signs Study Group
Apple (Israel) · ILBoston University · USChild Health Research Foundation · BDGates Foundation · USKwame Nkrumah University of Science and Technology · GH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundNeonatal illness is a leading cause of death worldwide; sepsis is one of the main contributors. The etiologies of community-acquired neonatal bacteremia in developing countries have not been well characterized.

methodsInfants <2 months of age brought with illness to selected health facilities in Bangladesh, Bolivia, Ghana, India, Pakistan and South Africa were evaluated, and blood cultures taken if they were considered ill enough to be admitted to hospital. Organisms were isolated using standard culture techniques.

resultsEight thousand eight hundred and eighty-nine infants were recruited, including 3177 0-6 days of age and 5712 7-59 days of age; 10.7% (947/8889) had a blood culture performed. Of those requiring hospital management, 782 (54%) had blood cultures performed. Probable or definite pathogens were identified in 10.6% including 10.4% of newborns 0-6 days of age (44/424) and 10.9% of infants 7-59 days of age (39/358). Staphylococcus aureus was the most commonly isolated species (36/83, 43.4%) followed by various species of Gram-negative bacilli (39/83, 46.9%; Acinetobacter spp., Escherichia coli and Klebsiella spp. were the most common organisms). Resistance to second and third generation cephalosporins was present in more than half of isolates and 44% of the Gram-negative isolates were gentamicin-resistant. Mortality rates were similar in hospitalized infants with positive (5/71, 7.0%) and negative blood cultures (42/557, 7.5%).

conclusionsThis large study of young infants aged 0-59 days demonstrated a broad array of Gram-positive and Gram-negative pathogens responsible for community-acquired bacteremia and substantial levels of antimicrobial resistance. The role of S. aureus as a pathogen is unclear and merits further investigation.

Indexed as

Anti-Bacterial AgentsBacteremiaBacteriological TechniquesCommunity-Acquired InfectionsDrug Resistance, BacterialFemaleGram-Negative BacteriaGram-Positive BacteriaHumansInfantInfant, NewbornMaleAnti-Bacterial Agents

Identifiers

PMID25389919
PMCPMC4272225
OpenAlexW1966119060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.